Showing results (121-130 of 451) with videos related to
Sort By:
Pageof 46
Rheumatology (Oxford, England)|February 24, 2026
A randomised open label pilot trial comparing mycophenolate mofetil with no immunosuppression in limited cutaneous systemic sclerosis (MINIMISE-Pilot)Christopher P Denton, Philip Yee, Medha Kanitkar, et al.Arthritis and Rheumatism|August 29, 2009
Loss of beta1 integrin in mouse fibroblasts results in resistance to skin scleroderma in a mouse modelShangxi Liu, Mohit Kapoor, Christopher P Denton, et al.Journal of Cell Communication and Signaling|April 23, 2009
Pericytes display increased CCN2 expression upon culturingXu Shiwen, Vineeth Rajkumar, Christopher P Denton, et al.Molecular Biology of the Cell|November 17, 2017
STAT3 controls COL1A2 enhancer activation cooperatively with JunB, regulates type I collagen synthesis posttranscriptionally, and is essential for lung myofibroblast differentiationIoannis Papaioannou, Shiwen Xu, Christopher P Denton, et al.Journal of the American Academy of Dermatology|February 8, 2022
Systemic sclerosis in adults. Part II: management and therapeuticsRebekka Jerjen, Mandana Nikpour, Thomas Krieg, et al.Arthritis Research & Therapy|September 15, 2007
Clinical trials and basic research: defining mechanisms and improving treatment in connective tissue diseaseLewis J Rubin, Carol M Black, Christopher P Denton, et al.Journal of Scleroderma and Related Disorders|June 8, 2023
Relapsing polychondritis in systemic sclerosis: A rare vasculitic mimicCarolina Teles, Chiranthi Kongala Liyanage, Geoffrey Chow, et al.Clinical Reviews in Allergy & Immunology|May 1, 2017
Intracellular B Lymphocyte Signalling and the Regulation of Humoral Immunity and AutoimmunityTaher E Taher, Jonas Bystrom, Voon H Ong, et al.Journal of Scleroderma and Related Disorders|March 24, 2025
Physician-patient communication in the treatment of systemic sclerosis-associated interstitial lung disease: A narrative review and recommendationsMasataka Kuwana, Aiko Saito, Sue Farrington, et al.Vascular Pharmacology|December 3, 2014
Reduced levels of S-nitrosothiols in plasma of patients with systemic sclerosis and Raynaud's phenomenonDevi Kundu, David Abraham, Carol M Black, et al.Pageof 46